New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches

TY - JOUR

T1 - New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches

AU - Schwedt, Todd J.

N1 - Funding Information: Conflict of Interest: Within the past 12 months, I have served as a consultant or advisory board member for Alder, Allergan, Amgen, Cipla, Dr. Reddy’s, Eli Lilly, Ipsen Bioscience, Novartis, Teva, XoC. I hold stock options in Aural Analytics, Nocira, and Second Opinion. I have received research funding from the American Migraine Foundation, Amgen, the Henry Jackson Foundation, National Institutes of Health, Patient Centered Outcomes Research Institute, and the U.S. Department of Defense. I serve on the Board of Directors for the American Headache Society and the International Headache Society.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85068878822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068878822&partnerID=8YFLogxK

U2 - 10.1111/head.13584

DO - 10.1111/head.13584

M3 - Editorial

C2 - 31291019

AN - SCOPUS:85068878822

SN - 0017-8748

VL - 59

SP - 1

EP - 2

JO - Headache

JF - Headache

IS - S2

ER -